-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KHHHafpKWO4OS19KZifBbQcJuH2JAODKewvNF/wwqCLdgCGZKKmsBpjcmDazCuN5 tJT+Q674NIh23GU37ZNv9Q== 0000898430-02-000640.txt : 20020414 0000898430-02-000640.hdr.sgml : 20020414 ACCESSION NUMBER: 0000898430-02-000640 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020214 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ANDERSON N LEIGH & SENIFF CONSTANCE CENTRAL INDEX KEY: 0001134604 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 55 WEST WATKING MILL ROAD CITY: GAITEHRSBURG STATE: MD ZIP: 20879 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LARGE SCALE BIOLOGY CORP CENTRAL INDEX KEY: 0001108951 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770154648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60663 FILM NUMBER: 02548687 BUSINESS ADDRESS: STREET 1: 3333 VACA VALLEY PKWY STREET 2: STE 1000 CITY: VACAVILLE STATE: CA ZIP: 95688 MAIL ADDRESS: STREET 1: 3333 VACA VALLEY PARKWAY SUITE 1000 CITY: VACAVILLE STATE: CA ZIP: 95688 SC 13G/A 1 dsc13ga.txt SCHEDULE 13G AMENDMENT #1 Page 1 of 6 Pages SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------------------------------------------- SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) (Amendment No. 1)/1/ Large Scale Biology Corporation - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 517053 10 4 - -------------------------------------------------------------------------------- (CUSIP Number) December 31, 2001 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) - ---------------- /1/ The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 2 of 6 Pages CUSIP NO. 517053 10 4 13G - ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS NORMAN LEIGH ANDERSON (SPOUSE OF CONSTANCE SENIFF) - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION UNITED STATES - ------------------------------------------------------------------------------- NUMBER OF SHARES 5 SOLE VOTING POWER 1,075,908 BENEFICIALLY --------------------------------------------------- OWNED BY 6 SHARED VOTING POWER EACH REPORTING --------------------------------------------------- PERSON WITH 7 SOLE DISPOSITIVE POWER 1,075,908 --------------------------------------------------- 8 SHARED DISPOSITIVE POWER - ------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING 1,401,135 PERSON (Norman Leigh Anderson disclaims beneficial ownership of any securities of Large Scale Biology Corporation owned by his spouse) - ------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - ------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.6% (Norman Leigh Anderson disclaims beneficial ownership of any securities of Large Scale Biology Corporation owned by his spouse) - ------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! Pae 3 of 6 Pages CUSIP NO. 517053 10 4 13G - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS CONSTANCE SENIFF (SPOUSE OF NORMAN LEIGH ANDERSON) - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION UNITED STATES - -------------------------------------------------------------------------------- NUMBER OF SHARES 5 SOLE VOTING POWER 325,227 BENEFICIALLY --------------------------------------------------- OWNED BY 6 SHARED VOTING POWER EACH REPORTING --------------------------------------------------- PERSON WITH 7 SOLE DISPOSITIVE POWER 325,227 --------------------------------------------------- 8 SHARED DISPOSITIVE POWER - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING 1,401,135 PERSON (Constance Seniff disclaims beneficial ownership of any securities of Large Scale Biology Corporation owned by her spouse) - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.6% (Constance Seniff disclaims beneficial ownership of any securities of Large Scale Biology Corporation owned by her spouse) - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! Page 4 of 6 Pages Item 1(a). Name of Issuer: Large Scale Biology Corporation Item 1(b). Address of Issuer's Principal Executive Offices: 3333 Vaca Valley Parkway, Suite 1000 Vacaville, CA 95688 Item 2(a)-(c). Name of Person Filing: This statement is being filed by Norman Leigh Anderson and Constance Seniff, husband and wife with business address at 20451 Goldenrod Lane, Germantown, MD 20879. Mr. Anderson and Ms. Seniff are United States citizens. Item 2(d). Title of Class of Securities: Common Stock Item 2(e). CUSIP Number: 517053 10 4 Item 3. If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b), check whether the person filing is a: Not Applicable Item 4. Ownership. See Items 5-11 of cover sheets hereto. Item 5. Ownership of Five Percent or Less of a Class. Not applicable Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not Applicable Item 8. Identification and Classification of Members of the Group. Not Applicable Item 9. Notice of Dissolution of Group. Not Applicable Item 10. Certification. Not Applicable Page 5 of 6 Pages SIGNATURES After reasonable inquiry and to the best of our knowledge and belief, we certify that the information set forth in this statement is true, complete and correct. We incorporate by reference herein the Powers of Attorney annexed to our Schedule 13G filed with the Securities and Exchange Commission on February 14, 2001. Date: February 14, 2002 /s/ Norman Leigh Anderson Signature: By: Gary Garrigues Attorney-in-Fact -------------------------------------- Norman Leigh Anderson By: Gary Garrigues Attorney-in-Fact /s/ Constance Seniff Signature: By: Gary Garrigues Attorney-in-Fact -------------------------------------- Constance Seniff By: Gary Garrigues Attorney-in-Fact Page 6 of 6 Pages EXHIBIT Agreement of Joint Filing This agreement is executed pursuant to 240 CFR ss. 13d-1(k)(1)(iii). The undersigned agree that for the purpose of compliance with Section 13 of the Securities Exchange Act of 1934, we shall file one schedule to report our holdings of securities in Large Scale Biology Corporation. Date: February 14, 2002 /s/ Norman Leigh Anderson Signature: By: Gary Garrigues Attorney-in-Fact -------------------------------------- Norman Leigh Anderson By: Gary Garrigues Attorney-in-Fact /s/ Constance Seniff Signature: By: Gary Garrigues Attorney-in-Fact -------------------------------------- Constance Seniff By: Gary Garrigues Attorney-in-Fact -----END PRIVACY-ENHANCED MESSAGE-----